MD · Insider Trading
Pediatrix Medical Group, Inc.
Every open-market purchase and sale reported by MD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Laura A Linynsky | Director | D | −6,000 | −$160.92K |
| 2026-08-18 | Sylvia Jean Young | Director | D | −18,500 | −$492.47K |
| 2026-08-14 | Laura A Linynsky | Director | A | +472 | +$12.51K |
| 2026-08-14 | Michael A. Rucker | Director | A | +472 | +$12.51K |
| 2026-08-14 | Sylvia Jean Young | Director | A | +472 | +$12.51K |
| 2026-08-14 | Kurt Douglas Newman | Director | A | +472 | +$12.51K |
| 2026-08-14 | Guy P Sansone | Director | A | +472 | +$12.51K |
| 2026-08-14 | Shirley A Weis | Director | A | +472 | +$12.51K |
| 2026-08-14 | Thomas McEachin | Director | A | +472 | +$12.51K |
| 2026-08-14 | John M. Starcher Jr. | Director | A | +472 | +$12.51K |
| 2026-06-24 | David Haddock | EVP, GC & Corp Sec | A | +20,036 | — |
| 2026-06-10 | Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | G | — | — |
| 2026-06-03 | Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | F | −11,944 | −$257.27K |
| 2026-06-03 | Kasandra H Rossi | EVP, CFO and Treasurer | MIXED | +28,099 | −$79.72K |
| 2026-06-03 | Mark S Ordan | Chief Executive Officer | MIXED | +108,079 | −$411.82K |
| 2026-06-03 | Don Gregory Neeb | EVP, Chief Invest & Strategy | MIXED | +55,885 | −$172.38K |
| 2026-05-14 | Shirley A Weis | Director | Sell | −36,028 | −$855.66K |
| 2026-05-14 | Thomas McEachin | Director | G | — | — |
| 2026-05-13 | Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | G | −40,826 | — |
| 2026-05-11 | Guy P Sansone | Director | A | +7,196 | — |
| 2026-05-11 | Shirley A Weis | Director | A | +7,196 | — |
| 2026-05-11 | John M. Starcher Jr. | Director | A | +7,196 | — |
| 2026-05-11 | Sylvia Jean Young | Director | A | +7,196 | — |
| 2026-05-11 | Thomas McEachin | Director | A | +7,196 | — |
| 2026-05-11 | Michael A. Rucker | Director | A | +7,196 | — |
| 2026-05-11 | Kurt Douglas Newman | Director | A | +7,196 | — |
| 2026-05-11 | Laura A Linynsky | Director | A | +7,196 | — |
| 2026-03-03 | Kasandra H Rossi | EVP, CFO and Treasurer | F | −3,676 | −$72.97K |
| 2026-03-03 | Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | MIXED | +12,994 | −$534.58K |
| 2025-12-17 | Mark S Ordan | Chief Executive Officer | Sell | −23,000 | −$515.43K |
| 2025-11-19 | Michael A. Rucker | Director | Sell | −10,478 | −$240.99K |
| 2025-11-10 | Laura A Linynsky | Director | Sell | −10,000 | −$216.50K |
| 2025-08-21 | Thomas McEachin | Director | G | −54,646 | — |
| 2025-08-05 | Kurt Douglas Newman | Director | A | +9,737 | — |
| 2025-08-05 | Don Gregory Neeb | EVP, Chief Invest & Strategy | A | +81,346 | — |
| 2025-06-12 | Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | G | −10,371 | — |
| 2025-06-03 | Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | MIXED | +46,275 | −$95.22K |
| 2025-06-03 | Mark S Ordan | Chief Executive Officer | A | +194,347 | — |
| 2025-06-03 | Kasandra H Rossi | EVP, CFO and Treasurer | MIXED | +25,825 | −$9.58K |
| 2025-05-27 | Shirley A Weis | Director | G | −18,360 | — |
| 2025-05-12 | Sylvia Jean Young | Director | A | +11,427 | — |
| 2025-05-12 | Thomas McEachin | Director | A | +11,427 | — |
| 2025-05-12 | Michael A. Rucker | Director | A | +11,427 | — |
| 2025-05-12 | John M. Starcher Jr. | Director | A | +11,427 | — |
| 2025-05-12 | Guy P Sansone | Director | A | +11,427 | — |
| 2025-05-12 | Shirley A Weis | Director | A | +11,427 | — |
| 2025-05-12 | Mark S Ordan | Chief Executive Officer | F | −7,225 | −$104.33K |
| 2025-05-12 | Laura A Linynsky | Director | A | +11,427 | — |
| 2025-03-07 | Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | G | −26,497 | — |
| 2025-03-04 | Kasandra H Rossi | EVP, CFO and Treasurer | F | −3,718 | −$54.91K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Mark S Ordan | Chief Executive Officer | 410,884 | $12.99M |
| Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | 189,890 | $6.00M |
| Don Gregory Neeb | EVP, Chief Invest & Strategy | 145,234 | $4.59M |
| Kasandra H Rossi | EVP, CFO and Treasurer | 105,100 | $3.32M |
| Guy P Sansone | Director | 87,416 | $2.76M |
| Thomas McEachin | Director | 73,741 | $2.33M |
| John M. Starcher Jr. | Director | 73,732 | $2.33M |
| Michael A. Rucker | Director | 66,769 | $2.11M |
| Laura A Linynsky | Director | 33,900 | $1.07M |
| Sylvia Jean Young | Director | 29,786 | $941.83K |
| David Haddock | EVP, GC & Corp Sec | 20,036 | $633.54K |
| Shirley A Weis | Director | 19,095 | $603.78K |
| Kurt Douglas Newman | Director | 17,405 | $550.35K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.